These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 16446560

  • 1. Cannabinoid receptor agonists inhibit Ca(2+) influx to synaptosomes from rat brain.
    Yoshihara S, Morimoto H, Ohori M, Yamada Y, Abe T, Arisaka O.
    Pharmacology; 2006; 76(4):157-62. PubMed ID: 16446560
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.
    Liu Q, Bhat M, Bowen WD, Cheng J.
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1062-70. PubMed ID: 19752241
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M, McCreary AC, Przegaliński E, Filip M.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):96-106. PubMed ID: 16730696
    [Abstract] [Full Text] [Related]

  • 5. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L, Howlett AC, Mukhopadhyay S.
    J Pharmacol Exp Ther; 2007 Jun 01; 321(3):930-7. PubMed ID: 17379772
    [Abstract] [Full Text] [Related]

  • 6. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR.
    J Pharmacol Exp Ther; 2006 Dec 01; 319(3):1211-8. PubMed ID: 16943255
    [Abstract] [Full Text] [Related]

  • 7. Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
    Cui YY, D'Agostino B, Risse PA, Marrocco G, Naline E, Zhang Y, Chen HZ, Finance O, Rinaldi-Carmona M, Rossi F, Advenier C.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):206-13. PubMed ID: 17643417
    [Abstract] [Full Text] [Related]

  • 8. First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain.
    Benamar K, Geller EB, Adler MW.
    J Pharmacol Exp Ther; 2008 May 14; 325(2):641-5. PubMed ID: 18281594
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system.
    Griffin G, Wray EJ, Tao Q, McAllister SD, Rorrer WK, Aung MM, Martin BR, Abood ME.
    Eur J Pharmacol; 1999 Jul 14; 377(1):117-25. PubMed ID: 10448934
    [Abstract] [Full Text] [Related]

  • 10. The cannabinoid receptor agonist WIN 55212-2 inhibits neurogenic inflammations in airway tissues.
    Yoshihara S, Morimoto H, Ohori M, Yamada Y, Abe T, Arisaka O.
    J Pharmacol Sci; 2005 May 14; 98(1):77-82. PubMed ID: 15888960
    [Abstract] [Full Text] [Related]

  • 11. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.
    Hasanein P, Parviz M, Keshavarz M, Javanmardi K.
    Clin Exp Pharmacol Physiol; 2007 May 14; 34(5-6):439-49. PubMed ID: 17439413
    [Abstract] [Full Text] [Related]

  • 12. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
    Shivachar AC.
    Biochem Pharmacol; 2007 Jun 15; 73(12):2004-11. PubMed ID: 17445778
    [Abstract] [Full Text] [Related]

  • 13. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
    Izzo AA, Mascolo N, Pinto L, Capasso R, Capasso F.
    Eur J Pharmacol; 1999 Nov 12; 384(1):37-42. PubMed ID: 10611417
    [Abstract] [Full Text] [Related]

  • 14. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.
    Köfalvi A, Rodrigues RJ, Ledent C, Mackie K, Vizi ES, Cunha RA, Sperlágh B.
    J Neurosci; 2005 Mar 16; 25(11):2874-84. PubMed ID: 15772347
    [Abstract] [Full Text] [Related]

  • 15. Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways.
    Yoshihara S, Morimoto H, Ohori M, Yamada Y, Abe T, Arisaka O.
    Int Arch Allergy Immunol; 2005 Sep 16; 138(1):80-7. PubMed ID: 16103691
    [Abstract] [Full Text] [Related]

  • 16. The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2.
    Darmani NA.
    Eur J Pharmacol; 2001 Oct 26; 430(1):49-58. PubMed ID: 11698062
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
    Yang W, Li Q, Wang SY, Gao F, Qian WJ, Li F, Ji M, Sun XH, Miao Y, Wang Z.
    Neuroscience; 2016 Jan 28; 313():213-24. PubMed ID: 26621126
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.
    Ihenetu K, Molleman A, Parsons M, Whelan C.
    Eur J Pharmacol; 2003 Mar 19; 464(2-3):207-15. PubMed ID: 12620515
    [Abstract] [Full Text] [Related]

  • 20. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice.
    Smith SR, Terminelli C, Denhardt G.
    J Pharmacol Exp Ther; 2000 Apr 19; 293(1):136-50. PubMed ID: 10734163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.